Non-Amyloid Imaging Studies

Alzheimer Disease | Clinical Trials

Several neurochemical changes besides an accumulation of amyloid occur in the brain in individuals with Alzheimer disease.  Researchers at IND are developing multiple imaging ligands to better understand the changes occurring in the brain in Alzheimer disease.  Imaging ligands to detect changes in the norepinepherine system and neuroinflammation are critical to the development of future medications.

PPMI Pre-Motor Arm

Clinical Trials | Parkinson Disease

The pre-motor arm of PPMI will enroll participants who do not have Parkinson’s disease and are living with one of three potential risk factors for PD.
If you do not have a diagnosis of Parkinson disease and are 60 years of age or older you can participate in the hyposmic (smell testing) arm of the study by going to: michaeljfox.org/takethesmellsurvery or by contacting the call center (877) 525 PPMI. For more information go to the press release by clicking here.